Form 4: Amphastar Pharmaceuticals Executive Yakob Liawatidewi Reports Tax Liability Share Withholding
SEC Form 4 Filing
Yakob Liawatidewi, EVP Corp Admin Center at Amphastar Pharmaceuticals, reports the withholding of 1,141 shares to cover tax liabilities related to vesting restricted stock units.
Summary
- On March 6, 2025, Yakob Liawatidewi, EVP Corp Admin Center at Amphastar Pharmaceuticals, reported a transaction on Form 4.
- The transaction involved the withholding of 1,141 shares of common stock at a price of $28.32 to cover tax liabilities related to the vesting of restricted stock units (RSUs).
- Following the transaction, Liawatidewi directly owns 72,834 shares of common stock and indirectly owns 2,459 shares through the Yakob and Sunmoon Trust dated July 25, 2013, where Liawatidewi serves as a trustee.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to tax obligations, so it doesn't significantly impact sentiment.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves the withholding of shares for tax purposes.
Key Dates
| Date | Description |
|---|---|
| July 25, 2013 | Date of the Yakob and Sunmoon Trust |
| 03/06/2025 | Date of the share withholding transaction |
| 03/10/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.